CHRS Gross Profit Growth

Coherus Oncology Inc · Gross Profit Growth

CHRS logo

CHRS Gross Profit Growth

Year-over-year change vs the same period a year earlier

Latest reported-59.57%
CHRS TTM Gross Profit YoY % (-65.16% → -59.57%)
High-resolution chart · PNG

CHRS gross profit growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Coherus Oncology Inc Gross Profit Growth — Trailing twelve months (TTM)
Period endingGross Profit Growth
-59.5676%
-74.3267%
-77.0814%
-60.429%
-5.9367%
31.2163%
8.5087%
-23.8164%
-6.23%
-21.0038%
-30.2975%
-28.4265%
-59.1327%
-56.6815%
-47.5911%
-44.1729%
-36.498%
-39.612%
-38.6156%
-32.7191%
-23.3216%
-2.1986%
29.2525%
132.0483%
620.6016%
997.8176%
418.6683%
277.3953%
150.427%
64.7979%
33.0851%
40.5808%
-176.9675%
-101.274%
-147.1088%
-296.0167%
78.0342%
68.2857%
64.7753%
71.0033%
-99.2545%
-203.9015%
-287.6204%
-366.8624%
-182.0224%
-119.5293%
-65.164%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.